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Abstract Alteration of the gut microbiota through diet and
environmental contaminants may disturb the mammalian di-
gestive system, leading to various diseases. Because most ex-
posure to environmentally pyrethroid pesticides such as per-
methrin (PERM) occurs through the diet, the commensal gut
microbiota is likely to be exposed to PERM. The study aimed
at evaluating the effect of low-dose exposure to PERM in
early life on the composition of fecal microbiota in rats.
Over a 4-month follow-up period, fecal microbiota and
short-chain fatty acids were measured in order to identify pos-
sible differences between PERM-treated rats and controls.
Further in vitro antimicrobial experiments were conducted to
establish the antibacterial activity of PERM against different
strains to obtainMinimal Inhibitory Concentrations. The main
finding focused on the reduced abundance of Bacteroides-
P re vo t e l l a -Po rphy romonas sp e c i e s , i n c r e a s ed
Enterobacteriaceae and Lactobacillus in PERM-treated rats
compared to controls. Changes of acetic and propionic acid
levels were registered in PERM-treated group. From in vitro
studies, PERM showed higher antibacterial activity against
beneficial bacter ia such as Bif idobacterium and
Lactobacillus paracasei, while to inhibit potential pathogens
as Staphylococcus aureus and Escherichia coli PERM con-
centration needed to be increased. In summary, exposure to
PERM could affect the fecal microbiota and could be a crucial
factor contributing to the development of diseases.
Keywords Permethrin .Postnatalexposure .Gutmicrobiota .
Short-chain fatty acids . Environmental contaminants
Introduction
Due to an increasing concern about adverse health conse-
quences, organophosphate, carbamate, and organochlorine are
being phased out leading to escalating use of an alternative class
of pesticides, the pyrethroids. Pyrethroids are now the most
commonly used pesticides for residential pest control, public
health purposes, and for agriculture with biomonitoring studies
confirming widespread exposure to one or more pyrethroids
(Williams et al. 2008; Morgan 2012; Barr et al. 2010; Heudorf
and Angerer 2001; Roberts et al. 2012). One of the main routes
of pyrethroid exposure involves dietary residues through food
contamination (Barr et al. 2010; Heudorf and Angerer 2001).
Although pyrethroid pesticides are often considered a
Bsafer^ choice because they are generally not as acutely toxic
as organophosphates (Casida and Durkin 2013), our studies
on adult and adolescent rats indicated that oral long-term ex-
posure to permethrin (PERM), one of the most representative
pyrethroid compound, may not be benign (Nasuti et al. 2003;
Gabbianelli et al. 2004; Nasuti et al. 2008). In particular,
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oxidative damage to lymphocyte and erythrocyte was ob-
served at doses of 150 mg/kg. However, a worst effect of
PERM was observed when it was administered to rat pups
during the suckling period from postnatal day (PND) 6 to
PND 21 at doses of 34 mg/kg close to the No Observed
Adverse Effects Levels (NOAEL) for PERM (25 mg/kg).
Daily oral dose of PERM for 15 days induced dopamine and
glutathione depletion together with lipid peroxidation in the
basal ganglia of brain (Nasuti et al. 2007).
In mammals, the postnatal period is characterized by the
progressive colonization of the gut ecosystem by bacteria ac-
quired during the delivery process, from the mother’s skin and
milk and other environmental and oral sources (Morelli 2008).
Subsequently, the presence of pesticide residues in food of
young animals could induce variations in the gut microbiota
that is essential for the development and maturation of gastro-
intestinal tract and enteric immune system, the maintenance of
barrier function and the provision of essential nutrients.
Furthermore, alterations in the colonization process predis-
pose and increase the risk to disease later in life.
Given that weaning is a critical period for bacterial profile
changes, we investigated, here, the impact of daily, oral expo-
sure to low-dose PERM (34 mg/kg), from PND 6 to PND 21,
on the fecal microbiota by using an in vivo model.
The changes over time in the populations of fecal micro-
flora were examined at four different time points: PND 21
(weaning), PND 51 (adolescent age), PND 81 and PND 141
(adulthood). In parallel, control rats were gavaged daily with
vehicle in order to establish possible differences between con-
trol and PERM-treated rats. In the same samples, wemeasured
the fecal levels of short-chain fatty acids (SCFAs), which are
the principle nutrient substrates of the intestinal epithelial cells
and are themselves produced by commensal anaerobic bacte-
ria via carbohydrate fermentation.
In vitro experiments were performed to establish the anti-
bacterial activity of PERM against 16 different strains (Gram-
positives, Gram-negatives and yeasts) in order to obtain
Minimal Inhibitory Concentrations (MICs). Moreover, we ex-
amined the effect of PERM on the relative levels of different
bacterial groups present in the human fecal microbiota using a
semi-continuous fermentor mimicking ileostomy fluid.
Materials and methods
In vitro studies
MICs of PERM
The in vitro experiments were performed using 16 different
strains: Gram-positives, Gram-negatives and yeasts. The
strains, their origins and their cultural and growth conditions
were described in the Table 1.
For each tested strains MIC was determined using a broth
microdilution method with a 96-well microtiter plate (Clinical
and Laboratory Standards Institute 2007). One series of 2-fold
dilutions of PERM in dimethyl sulfoxide and distilled water
(DMSO:H2O ranging from 3.2 to 0.00625 mg/mL) for each
microbial strain was prepared using the meanmentioned in the
supplementary material. Each series was inoculated with
0.8 μL of each microbial strain (1.5×108 cells/ml). MIC de-
termination, as the lowest concentration of PERM that
inhibited the visible growth of the microorganisms after over-
night/24/48 h of incubation at 37 °C, was carried out evaluat-
ing the microbial growth in the wells using a stereomicroscope
(GSZ2, Ascania, Germany).
Fermentation study
The medium used in this semi-continuous fermenter system
was complex and designed to mimic either ileostomy fluid or
ileal chime. The composition and the addition of fecal fluid
and primary bile acids in the medium were those reported by
Zampa et al. (2004). Two experiments were performed (with
three replicates for each): (i) a fermentation with semi-
continuous culture with the addition of glucose in the medium
(control test); (ii) a fermentation with semi-continuous culture
with addition of 6 mL of PERM (1.28 mg in corn oil) in the
medium each day. Each fermentation was run for 5 days.
A pool of freshly voided fecal samples from healthy vol-
unteers with no history of gastrointestinal disease, both before
and during the sampling period, and not undergoing antibiotic
therapy one month prior to sampling, was used as inoculum.
The procedures used in preparing the inoculum were reported
in Zampa et al. (2004).
The viable bacteria count (aerobes and anaerobes) was
estimated by spreading tenfold dilutions of the original
sample into selective agars (Silvi et al. 1996; Zampa
et al. 2004). The bacteriological analysis was performed
at different times of fermentation: immediately after in-
oculation (0 h), 24, 48, 72, and 96 h. The agar plates
were spread in duplicate with 50 μL of diluted sample
and then incubated in aerobic and anaerobic conditions at
37 °C for 24–72 h.
In vivo studies
Materials
Technical grade (75: 25, trans: cis; 94 % purity) 3-
phenoxybenzyl-(1R,S)-cis,trans-3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecarboxyl-ate, PERM (NRDC 143)were
generously donated by Dr. A. Stefanini of ACTIVA (Milan,
Italy). Corn oil was obtained from Sigma (Milan, Italy).
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Animals and treatment
Male and female Wistar rats aged about 90 days weighing 250-
270 g were obtained from Charles River (Calco, LC, Italy). The
animals were housed in plastic (Makrolon) cages (five rats/
cage) in a temperature controlled room (21±5 °C) and main-
tained on a standard GLP diet (4RF21,Mucedola S.r.l., Settimo
Milanese,Milan, Italy) with water ad libitum. The composition
of the standard diet was: raw proteins 167.4 g/kg, raw fats
20.0 g/kg, raw fibers 71.7 g/kg, raw ashes 63.3 g/kg.
The light/dark cycle was from 7 a.m. to 7 p.m. Male rat
pups born in our laboratory from primiparous dams were used
in the study. PERM-treated rats were treated daily by gavage
with a PERM solution (34 mg/4 mL/kg body weight) from
PND 6 to PND 21, whereas control rats were treated with the
vehicle (corn oil 4 mL/kg body weight) on a similar schedule
as previously described (Nasuti et al. 2013). The PERM solu-
tion was obtained by dissolving PERM in corn oil. Both con-
trol and PERM-treated groups were given free access to stan-
dard rat diet.
All procedures were carried out in accordance with the
European guidelines (Directive 2010/63/EU) for the care
and use of laboratory animals.
Experimental design
At the end of the treatment (PND 21) with PERM or vehicle,
fecal pellets were freshly collected from six PERM-treated
and six control rats; pellets were stored at −80 °C until anal-
ysis of the microbiota by RT-PCR. Moreover, at PND 51, 81,
and 141, fecal pellets were again collected and stored at
−80 °C until analysis to quantify selected bacterial strains
and SCFAs.
For collection of feces, rats were held in metabolic cages.
After 24 h, fecal output and food intake were measured.
Bacterial quantification by RT-PCR from fecal sample
A Real-Time quantitative PCR (QPCR) procedure was used
for the quantification of the main bacterial groups of rats’
intestinal microbiota by using specific primers, chosen from
literature (Rinttila et al. 2004; Fang and Hedin 2003; Byun
et al. 2004; Langendijk et al. 1995; Bartosch et al., 2004) as
shown in the Table 2. From each fecal sample the DNAwas
extracted using Stool DNA isolation kit (Norgen, Thorold,
Canada). SYBR Green Real-Time PCR amplification was
performed in triplicate using an iCycler iQ Real-Time
Detection System (Stratagene) associated with MXP
Software using the conditions reported in the supplementary
material. For quantification of the above-mentioned target
groups of bacteria, standard curves, previously generated for
each of them as reported by Avella et al. (2010), were used.
SCFA analysis
Six feces samples for each rat group (one feces sample for
each rat) were analyzed by headspace solid-phase
microextraction coupled to gas-chromatography equipped
with flame ionization detection as previously reported
(Fiorini et al. 2015).
The results were expressed as μmol/g feces. The precision,
as average of the relative standard deviation percentages,
Table 1 Target strains used for MIC determination, their origin, cultural, and growth conditions
Strain Strain code Origin Cultural and growth conditions
Gram-positives Bacillus subtilis ATCC 6633 Culture collection TSB, 24 h at 37 °C, aerobiosis
Blautia producta DSM 2950 Culture collection MRS enriched with Cysteine, 24–48 h at 37 °C, anaerobiosis
Bifidobacterium spp. A1 Human intestinal tract MRS enriched with Cysteine, 24–48 h at 37 °C, anaerobiosis
Bifidobacterium spp. A2 Human intestinal tract MRS enriched with Cysteine, 24–48 h at 37 °C, anaerobiosis
Bifidobacterium spp. B1 Human intestinal tract MRS enriched with Cysteine, 24–48 h at 37 °C, anaerobiosis
Bifidobacterium spp. F1 Human intestinal tract MRS enriched with Cysteine, 24–48 h at 37 °C, anaerobiosis
Enterococcus faecalis ATCC 29218 Culture collection TSB, 24 h at 37 °C, aerobiosis
Lactobacillus paracasei IMC 502® Human intestinal tract MRS with Vancomycin, 48 h at 37 °C, aerobiosis
Lactobacillus plantarum IMC 512® Human intestinal tract MRS with Vancomycin, 48 h at 37 °C, aerobiosis
Lactobacillus rhamnosus IMC 501® Human intestinal tract MRS with Vancomycin, 48 h at 37 °C, aerobiosis
Staphylococcus aureus ATCC 25923 Culture collection TSB, 24 h at 37 °C, aerobiosis
Streptococcus mutans ATCC 20523 Culture collection TSB, 24 h at 37 °C, aerobiosis
Gram-negatives Escherichia coli ATCC 13706 Culture collection TSB, 24 h at 37 °C, aerobiosis
Pseudomonas aeruginosa DSM 1117 Culture collection TSB, 24 h at 37 °C, aerobiosis
Yeasts Candida albicans ATCC 14053 Culture collection SAB, 24 h at 37 °C, aerobiosis
Candida albicans ATCC 10261 Culture collection SAB, 24 h at 37 °C, aerobiosis
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obtained analyzing independent replicates of each homoge-
nized sample, was: 3.8 % (n=36) for acetic acid, with a range
of 0.3–13.2 %; 4.4 % (n=36) for propionic acid, with a range
of 0.6–13.8 %; 4.9 % (n=36) for butyric acid, with a range of
0.9–13.0 %.
Statistical analysis
Data were presented as means± standard deviation unless in-
dicate otherwise. Bacterial data were expressed as mean of
log10 CFU/g. For the fecal analysis in the in vivo study, a
two-way ANOVAwith one factor within (time) and one factor
between (treatment) was employed. When appropriate, post
hoc analysis was carried out using the Newman-Keul test.
Statistical significance was set at P<0.05.
Results
MICs of PERM
The MIC results of PERM on the bacterial strains tested were
showed in the Table 3. PERM had inhibitory activity against
both Gram-positive and Gram-negative bacteria.
Within the Gram-positives, Blautia producta DSM 2950
and Bifidobacterium spp. B1 were highly sensitive to PERM
with MIC value of 0.4 μg/mL for both of them. On the con-
trary, either E. coli ATCC 13706 and Ps. aeruginosa DSM
1117, both Gram-negative, were less sensitive to PERM with
values of 1.6 μg/mL for both of them. Also the two Candida
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Table 3 Antimicrobial activity of permethrin given as minimal
inhibitory concentration (MIC)
Strains MIC (μg/mL)a
Gram-positives Bacillus subtilis ATCC 6633 3.2
Blautia producta DSM 2950 0.4
Bifidobacterium spp. A1 0.8
Bifidobacterium spp. A2 0.8
Bifidobacterium spp. B1 0.4
Bifidobacterium spp. F1 0.8
Enterococcus faecalis ATCC 29218 1.6
Lactobacillus paracasei IMC 502® 0.8
Lactobacillus plantarum IMC 512® 1.6
Lactobacillus rhamnosus IMC 501® 1.6
Staphylococcus aureus ATCC 25923 3.2
Streptococcus mutans ATCC 20523 0.8
Gram-negatives Escherichia coli ATCC 13706 1.6
Pseudomonas aeruginosa DSM 1117 1.6
Yeasts Candida albicans ATCC 14053 0.8
Candida albicans ATCC 10261 0.8
aMean of three determinations
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strains were inhibited by values of 0.8 μg/mL of PERM. From
the point of view of beneficial and potential pathogen bacteria,
PERM was effective with lower concentration on beneficial
bacteria such as Bifidobacterium spp. and Lact. paracasei
IMC 502®. While higher concentration was needed to inhibit
potential pathogens such as Staphylococcus aureus, Bacillus
subtilis, E. coli and Pseudomonas aeruginosa. In the range of
pathogens more sensitive were the yeast strains as they
required a low amount of this compound to be inhibited.
Effect of PERM on human fecal microflora
in a semi-continuous fermentor
The bacterial counts on the fermentation samples related to all
the studied bacterial groups and to all established time points
did not show significant modulatory effect of PERM treatment
within 96 h of fermentation in a semi-continuous fermentor
mimicking ileotomy fluid when compared with fermentation
samples treated with glucose (data not shown).
Effect of PERM on fecal microflora in rats
The standard curves had a very high efficiency (%), correla-
tion coefficient (R2) and slope obtained by plotting the thresh-
old cycle values against the target DNA starting quantity.
Using the formula E= [10(−1/slope)−1], the efficiencies for
the individual assays were between 87.0 and 103.4 %. All of
these parameters indicated a very good quality of the con-
structed standard curves and so a precise and accurate
quantification of the samples. The results from the analysis
of rat fecal samples were showed in Table 4.
For Bacteroides-Prevotella-Porphyromonas spp., signifi-
cant differences between control and PERM-treated groups
were observed (F[1, 4] = 14.0, P = 0.019). Post hoc test
showed that the PERM-treated group displayed a significant
increase in these bacterial species at PND 21 (P=0.043) and
PND 51 (P=0.021). Conversely, at PND 141, the levels of
these species were significantly reduced in PERM-treated rats
compared with controls (P=0.019).
For Staphylococcus spp. and Bifidobacterium spp., results
revealed no significant difference between control and
PERM-treated groups (Staphylococcus spp.: F[1, 4] = 0.68,
P>0.05; Bifidobacterium spp.: F[1, 4] =1.703, P>0.05) at
all time points.
For Lactobacillus spp., significant differences between
control and PERM-treated groups were observed (F[1,
4]=32.82, P=0.004). In particular, post hoc test demonstrat-
ed that this bacterial species was significantly higher in
PERM-treated group compared with that of controls at PND
21 (P=0.001) and PND 51 (P=0.022).
For Enterobacteriaceae, ANOVA revealed a significant
treatment x time interaction (F[3, 12] =4.23, P=0.029), but
not a significant effect of treatment (F[1, 4]=4.54, P=0.10).
Post hoc analysis revealed that this bacterial family was sig-
nificantly more abundant in PERM-treated rats than in con-
trols at PND 51 (P=0.01).
At all time points (PND 21, 51, 81, and 141), daily fecal
output and food intake were measured in PERM-treated and
control groups. No differences were reported between PERM-
Table 4 Bacterial species quantified using 16S rDNA tags in fecal samples of control and PERM-treated rats over a 4-month follow-up period
Bacteria target Group Bacterial concentration (log10 CFU/g)
Treatment follow-up
PND 21 PND 51 PND 81 PND 141
Bacteroidetes Bacteroides-Prevotella-
Porphyromonas spp.
Control 7.29 ± 0.15 7.17 ± 0.02 7.19± 0.03 7.00 ± 0.05
PERM 7.53± 0.09* 7.58 ± 0.02* 7.24± 0.01 6.77 ± 0.15*
Firmicutes Staphylococcus spp. Control 5.95 ± 0.07 5.10 ± 0.02 5.87± 0.08 5.58 ± 0.18
PERM 6.14± 0.22 5.91 ± 0.18 5.74± 0.16 5.30 ± 0.21
Clostridium coccoides-
Eubacterium rectale group
Control Not determined Not determined Not determined 9.73 ± 0.07
PERM Not determined Not determined Not determined 9.72 ± 0.16
Lactobacillus spp. Control 3.59 ± 0.04 3.42 ± 0.02 3.98± 0.04 3.87 ± 0.11
PERM 4.08± 0.07* 3.85 ± 0.01* 4.11 ± 0.06 3.79 ± 0.17
Actinobacteria Bifidobacterium spp. Control 4.51 ± 1.05 4.60 ± 0.06 5.00± 0.18 3.75 ± 0.12
PERM 5.27± 0.54 5.29 ± 0.12 5.12± 0.17 3.57 ± 0.19
Proteobacteria Enterobacteriaceae Control 3.99 ± 0.26 3.23 ± 0.11 4.41± 0.05 4.10 ± 0.18
PERM 4.37± 0.12 3.82 ± 0.07* 4.34± 0.10 4.14 ± 0.28
Data are expressed as mean of log10 CFU/g ± standard deviation
*P< 0.05 vs control group
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treated and control groups (daily fecal output: F[1, 10]=0.003,
P=0.95; daily food intake: F[1, 10]=0.43, P=0.52).
Effect of PERM on fecal SCFA in rats
Acetic acid, propionic acid and butyric acid levels were re-
ported in Fig. 1.
For acetic acid, two-way ANOVA revealed a significant
treatment x time interaction (F[3, 12] =4.74, P=0.020), but
not a significant effect of treatment (F[1,4]=1.94, P>0.05) as
shown in Fig. 1a. Post hoc analysis revealed that this SCFA
was significantly lower in PERM-treated rats than in controls
at PND 21 (P=0.017).
For propionic acid, two-way ANOVA revealed a signifi-
cant treatment x time interaction (F[3,12]=4.83, P=0.019),
but not a significant effect of treatment (F[1,4] = 0.004,
P>0.05) as shown in Fig. 1b. Post hoc analysis revealed that
propionic acid was significantly higher in PERM-treated rats
than in controls at PND 51 (P=0.003).
For butyric acid, results revealed no significant treatment x
time interaction (F[3,12] =3.052, P=0.069) and no signifi-
cant difference between control and PERM-treated groups
(F[1,4]=0.35, P>0.05) at all time points (Fig. 1c).
Discussion
In previous studies, we demonstrated significant effects of
permethrin especially on CNS when rat pups were orally ex-
posed to doses (34 mg/kg) close to the NOAEL for PERM
(25 mg/kg) (Carloni et al. 2012; Gabbianelli et al. 2014;
Nasuti et al. 2007, 2013, 2014). This pesticide belongs to the
pyrethroid family and it is widely used in agriculture, in in-
door environments such as households, warehouses, farm and
public buildings for pest-control purposes. Consumption of
fresh and cooked fruit and vegetables has been linked to
higher levels of exposure, as confirmed by the quantification,
in human urine, of the 3-phenoxybenzoic acid, the major me-
tabolite of PERM (Barr, et al. 2010). Although the digestive
tract is the first organ to come in contact with food contami-
nants, little is known about the digestive impact of PERM.
There are several studies on chlorpyrifos, a pesticide belong-
ing to the organophosphate insecticide, demonstrating how
low-dose exposure in perinatal age induces changes in gut
microbiota and disrupts gut mucosal barrier (Joly et al.
2013; Joly Condette et al. 2015), but no research on PERM
impact on intestinal microbiota has yet been performed.
Since that the population is widely exposed to this pesti-
cide, in this study we attempted to elucidate if early life expo-
sure to PERM could affect gut microbiota monitoring the
microbiota evolution over a 4-month follow-up period.
The main finding emerged from this study focused on the
reduced abundance o f Bac te ro ides -Prevo te l la -
Porphyromonas species in PERM-treated rats compared to
controls at the end of the 4-month follow-up period. In this
period of life, the present animal model develops motor dis-
abilities similar of that observed in animal models of
Parkinson’s disease (paper under submission). The decrease
of Prevotella family is associated with dysbiosis of the fecal
microbiota in patients with Parkinson’s disease (Scheperjans
et al. 2015).
Bacteroides species are responsible to produce higher
levels of SCFA whose protective role against gut
Fig. 1 Quantification of a acetic, b propionic, and c butyric acids,
expressed as μmol/g feces, in control and PERM-treated rats over a 4-
month follow-up period. Bars represent means ± standard deviation
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inflammation has been well proven (Scheppach et al. 2004).
Among them, butyrate plays a particular role for maintaining
the intestinal barrier, as shown in inflammatory bowel disease,
in which deficit in butyrate causes tight junction lesions and
finally impaired intestinal permeability. However, in the pres-
ent study, no decrease in fecal butyrate was observed in
PERM-treated rats versus controls across all times of
observation. On the contrary, differences between
PERM-treated and control groups were observed for
acetic and propionic acids. At the end of the last treat-
ment with PERM (PND 21), acetic acid was decreased
in feces of PERM-treated group compared to control. At
PND 51, propionic acid was increased in PERM-treated
rats. Considering that both groups were fed with the
same laboratory diet and no difference was observed
in daily food intake and fecal output, the results let us
to speculate that PERM treatment could be responsible
for the disruption of microbiota composition followed
by changes on the end products of fermentation.
Particularly, nondigestible carbohydrates are fermented
in the proximal colon by primary fermenters like
Bacteroides that produce CO2 and lactate. The first is
converted to acetic acid by acetogens via the Wood-
Ljungdahl pathway, whereas the second is reduced to
propionic acid by other members of the microbial com-
munity through the acrylate pathway (Den Besten et al.
2013). Here, in the PERM-treated rats, the bacterial
pathway related to acetic acid seems to be partially sup-
pressed whereas the pathway related to propionic acid
production appears to dominate over those observed in
the control rats. Although diet is a major determinant of
gut microbiota, the ingestion of exogenous compound
like permethrin may exert a strong influence on the
colonic milieu and on the microbial population which
in turn affects SCFA production.
Regarding Enterobacteriaceae, which contains most
of the opportunistic pathogens, the results showed a
trend to a slight increment in their abundance in
PERM-treated rats compared to controls at PND 21
followed by a significant increase at PND 51 the second
end point. The increase of this bacteria family, especial-
ly the pathogenic Escherichia coli strain, is associated
with dysbiosis of the fecal microbiota in patients with
Parkinson’s disease (Scheperjans et al. 2015). Hence,
the oral treatment with PERM appears to have
changed the normal microenvironment that is suitable
for beneficial populations, thereby allowing opportunistic
pathogens like Enterobacteriaceae to invade and colonize.
However, at PND 81 and PND 141, the Enterobacteriaceae
abundance in PERM-treated rats were similar to controls;
most probably compensatory mechanisms intervene to miti-
gate the gut microbiota unbalance observed at the previous
time points.
Indeed, the increase of Lactobacillus observed in
PERM-treated rats, at PND 21 and PND 51, could rep-
resent a compensatory response that, most probably, had
prevented the pathogenic Enterobacteriaceae overgrowth
at PND 81 and PND 141. Moreover, the findings of in
vitro studies ruled out the possibility that PERM in the
gut had a trophic effect on lactobacillus because the
latter was very sensitive to PERM as shown by a MIC
value of 0.8 μg/mL.
In the fermentation experiment performed on human
fecal microflora, PERM did not have modulatory effects
on all bacteria species analyzed. However, Kaufman
(1977) found that PERM residues had a short-term in-
hibitory effect on the functional diversity of soil mi-
crobes because microbes can use low-dose PERM as a
source of phosphorus or carbon. In the present study,
PERM may have a similar impact on bacterial strains.
Further, Wagenet (1985) showed that the addition of
nutrients to soil may increase the degradation of
PERM. Accordingly, we suggest that the addition of
low-dose PERM, in these experimental conditions, could
be used as an energy source providing a strong benefit
to the bacteria species, in fact we observed the same
effect when the fermentation was done with addition
of glucose.
In conclusion, our data demonstrated that low-dose
postnatal exposure to PERM affects negatively the gut
microbiota in rats with a decrease in numbers of some
strains such as Prevotella that might have a negative
impact on gut health. Further studies are warranted to
detect the impact of PERM on intestinal mucosa and to
include other bacterial families that may increase accu-
racy, and the potential of fecal microbiome analysis as a
biomarker able to detect diseases.
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